These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9631939)

  • 41. A model system for the investigation of urinary stone formation.
    Bouropoulos N; Bouropoulos C; Klepetsanis PG; Melekos M; Barbalias G; Koutsoukos PG
    Br J Urol; 1996 Aug; 78(2):169-75. PubMed ID: 8813906
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Citrate determines calcium oxalate crystallization kinetics and crystal morphology-studies in the presence of Tamm-Horsfall protein of a healthy subject and a severely recurrent calcium stone former.
    Hess B; Jordi S; Zipperle L; Ettinger E; Giovanoli R
    Nephrol Dial Transplant; 2000 Mar; 15(3):366-74. PubMed ID: 10692522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cooperation of phosphates and carboxylates controls calcium oxalate crystallization in ultrafiltered urine.
    Grohe B; Chan BP; Sørensen ES; Lajoie G; Goldberg HA; Hunter GK
    Urol Res; 2011 Oct; 39(5):327-38. PubMed ID: 21234554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Growth retardation of weddellite (calcium oxalate dihydrate) by sodium copper chlorophyllin.
    Tawashi R; Cousineau M
    Invest Urol; 1980 Sep; 18(2):86-9. PubMed ID: 7437122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Calcium oxalate lithiasis. Relationship between biochemical risk factors and crystalline phase of the stone].
    Parent X; Boess G; Brignon P
    Prog Urol; 1999 Dec; 9(6):1051-6. PubMed ID: 10658250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of seed crystals of hydroxyapatite and brushite on the crystallization of calcium oxalate in undiluted human urine in vitro: implications for urinary stone pathogenesis.
    Grover PK; Kim DS; Ryall RL
    Mol Med; 2002 Apr; 8(4):200-9. PubMed ID: 12149569
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of urinary macromolecule heparin on aggregation of nano-COM and nano-COD crystals.
    Ou Y; Xue JF; Tan CY; Gui BS; Sun XY; Ouyang JM
    Molecules; 2015 Jan; 20(1):1626-42. PubMed ID: 25608044
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The influence of hydroxyapatite and pyrophosphate on the formation product of calcium oxalate at different pHs.
    Baumann JM; Ackermann D; Affolter B
    Urol Res; 1989; 17(3):153-5. PubMed ID: 2546312
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of glycoproteins in calcium oxalate crystal development.
    Grases F; Isern B; Perelló J; Costa-Bauzá A
    BJU Int; 2004 Jul; 94(1):177-81. PubMed ID: 15217456
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Architecture of mixed calcium oxalate dihydrate and monohydrate stones.
    Iwata H; Iio S; Nishio S; Takeuchi M
    Scanning Microsc; 1992 Mar; 6(1):231-7; discussion 237-8. PubMed ID: 1626242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of urine on "in vitro" crystallization rate of calcium oxalate: determination of inhibitory activity by a [14C]oxalate technique.
    Ligabue A; Fini M; Robertson WG
    Clin Chim Acta; 1979 Oct; 98(1-2):39-46. PubMed ID: 227625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aggregation and dispersion characteristics of calcium oxalate monohydrate: effect of urinary species.
    Christmas KG; Gower LB; Khan SR; El-Shall H
    J Colloid Interface Sci; 2002 Dec; 256(1):168-74. PubMed ID: 12505509
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urolithiasis inhibitors and calculus nucleation.
    Grases F; Gil JJ; Conte A
    Urol Res; 1989; 17(3):163-6. PubMed ID: 2546313
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of calcium oxalate monohydrate crystallization by citrate through selective binding to atomic steps.
    Qiu SR; Wierzbicki A; Salter EA; Zepeda S; Orme CA; Hoyer JR; Nancollas GH; Cody AM; De Yoreo JJ
    J Am Chem Soc; 2005 Jun; 127(25):9036-44. PubMed ID: 15969581
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of calcium oxalate crystal growth and aggregation by prothrombin and its fragments in vitro: relationship between protein structure and inhibitory activity.
    Grover PK; Ryall RL
    Eur J Biochem; 1999 Jul; 263(1):50-6. PubMed ID: 10429186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Morphology, particle size distribution, aggregation, and crystal phase of nanocrystallites in the urine of healthy persons and lithogenic patients.
    He JY; Deng SP; Ouyang JM
    IEEE Trans Nanobioscience; 2010 Jun; 9(2):156-63. PubMed ID: 20423812
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calcium oxalate crystallization in urine: role of urate and glycosaminoglycans.
    Grover PK; Ryall RL; Marshall VR
    Kidney Int; 1992 Jan; 41(1):149-54. PubMed ID: 1593851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A non-classical view on calcium oxalate precipitation and the role of citrate.
    Ruiz-Agudo E; Burgos-Cara A; Ruiz-Agudo C; Ibañez-Velasco A; Cölfen H; Rodriguez-Navarro C
    Nat Commun; 2017 Oct; 8(1):768. PubMed ID: 28974672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of calcium oxalate monohydrate crystallization kinetics in vitro.
    Kok DJ; Papapoulos SE; Blomen LJ; Bijvoet OL
    Kidney Int; 1988 Sep; 34(3):346-50. PubMed ID: 2459439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.